Page last updated: 2024-10-18

dihydroxyphenylalanine and Restless Leg Syndrome

dihydroxyphenylalanine has been researched along with Restless Leg Syndrome in 5 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"We studied six restless legs syndrome (RLS) patients with [F18]fluorodeoxyglucose (FDG) positron emission tomography (PET)."1.30Positron emission tomographic studies in restless legs syndrome. ( Antonini, A; Chokroverty, S; Dhawan, V; Eidelberg, D; Hening, WA; Trenkwalder, C; Walters, AS, 1999)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, K1
Allen, RP1
Connor, JR1
Hyland, K1
Earley, CJ1
Trenkwalder, C1
Walters, AS1
Hening, WA1
Chokroverty, S1
Antonini, A1
Dhawan, V1
Eidelberg, D1
Turjanski, N1
Lees, AJ1
Brooks, DJ1
Ruottinen, HM1
Partinen, M1
Hublin, C1
Bergman, J1
Haaparanta, M1
Solin, O1
Rinne, JO1

Other Studies

5 other studies available for dihydroxyphenylalanine and Restless Leg Syndrome

ArticleYear
What is clinically significant RLS and who decides about its treatment?
    Sleep medicine, 2010, Volume: 11, Issue:1

    Topics: Cross-Sectional Studies; Dihydroxyphenylalanine; Humans; Restless Legs Syndrome

2010
Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis.
    Sleep medicine, 2009, Volume: 10, Issue:1

    Topics: Adult; Aged; Biomarkers; Circadian Rhythm; Dihydroxyphenylalanine; Dopamine; Female; Humans; Linear

2009
Positron emission tomographic studies in restless legs syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Brain; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male

1999
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
    Neurology, 1999, Mar-23, Volume: 52, Issue:5

    Topics: Aged; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinet

1999
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.
    Neurology, 2000, Jan-25, Volume: 54, Issue:2

    Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged;

2000